Insulin Treatment May Alter Fatty Acid Carriers in Placentas from Gestational Diabetes Subjects
AbstractThere is little information available on the effect of Gestational diabetes mellitus (GDM) treatment (diet or insulin) on placental lipid carriers, which may influence fetal fat accretion. Insulin may activate placental insulin receptors protein kinase (AKT) and extracellular signal regulated kinase ERK mediators, which might affect lipid metabolism. Placenta was collected from 25 control women, 23 GDM-Diet and 20 GDM-Insulin. Western blotting of insulin signaling mediators and lipid carriers was performed. The human choricarcinoma-derived cell line BeWo was preincubated with insulin inhibitors protein kinase (AKT) and extracellular signal regulated kinase (ERK) and ERK inhibitors to evaluate insulin regulation of lipid carriers. Maternal serum insulin at recruitment correlated to ultrasound fetal abdominal circumference in offspring of GDM and placental endothelial lipase (EL). Lipoprotein lipase in placenta was significantly reduced in both GDM, while most of the other lipid carriers tended to higher values, although not significantly. There was a significant increase in both phosphorylated-Akt and ERK in placentas from GDM-Insulin patients; both were associated to placental fatty acid translocase (FAT), fatty acid binding protein (A-FABP), and EL. BeWo cells treated with insulin pathway inhibitors significantly reduced A-FABP, fatty acid transport protein (FATP-1), and EL levels, confirming the role of insulin on these carriers. We conclude that insulin promotes the phosphorylation of placental insulin mediators contributing to higher levels of some specific fatty acid carriers in the placenta and fetal adiposity in GDM. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ruiz-Palacios, M.; Prieto-Sánchez, M.T.; Ruiz-Alcaraz, A.J.; Blanco-Carnero, J.E.; Sanchez-Campillo, M.; Parrilla, J.J.; Larqué, E. Insulin Treatment May Alter Fatty Acid Carriers in Placentas from Gestational Diabetes Subjects. Int. J. Mol. Sci. 2017, 18, 1203.
Ruiz-Palacios M, Prieto-Sánchez MT, Ruiz-Alcaraz AJ, Blanco-Carnero JE, Sanchez-Campillo M, Parrilla JJ, Larqué E. Insulin Treatment May Alter Fatty Acid Carriers in Placentas from Gestational Diabetes Subjects. International Journal of Molecular Sciences. 2017; 18(6):1203.Chicago/Turabian Style
Ruiz-Palacios, Maria; Prieto-Sánchez, Maria T.; Ruiz-Alcaraz, Antonio J.; Blanco-Carnero, José E.; Sanchez-Campillo, Maria; Parrilla, Juan J.; Larqué, Elvira. 2017. "Insulin Treatment May Alter Fatty Acid Carriers in Placentas from Gestational Diabetes Subjects." Int. J. Mol. Sci. 18, no. 6: 1203.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.